Skip to main content

and
  1. No Access

    Chapter

    Cancer

    A number of lifestyle factors affect cancer risk and survival, including nutrition and eating patterns, overweight and obesity status, physical activity and sedentary behavior, and alcohol and tobacco use. Mor...

    Elaine Trujillo, Barbara K. Dunn, Peter Greenwald in Lifestyle Medicine (2016)

  2. Article

    Future directions in cancer prevention

  3. In the past three decades, the approach to cancer prevention has moved from population and epidemiological studies to molecular targeting and immunological app...

  4. Asad Umar, Barbara K. Dunn, Peter Greenwald in Nature Reviews Cancer (2012)

  5. Article

    Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug

    Tamoxifen is a drug that has been in worldwide use for the treatment of estrogen receptor (ER)-positive breast cancer for over 30 years; it has been used in both the metastatic and adjuvant settings. Tamoxifen...

    Matteo Lazzeroni, Davide Serrano, Barbara K Dunn in Breast Cancer Research (2012)

  6. No Access

    Chapter

    Prostate Cancer Prevention and the Selenium and Vitamin E Cancer Prevention Trial (SELECT): A Selenium Perspective

    The Selenium and Vitamin E Cancer Prevention Trial (SELECT) randomized 35,533 healthy men, ≥55 years (≥50 years if African American), with normal digital rectal exams and prostate-specific antigens <4 ng/mL, t...

    Barbara K. Dunn, Philip R. Taylor in Selenium (2012)

  7. No Access

    Article

    Update on Phase I/II Breast Cancer Prevention Trials

    The greatest success in breast cancer prevention has been with two agents, tamoxifen and raloxifene, both of which are approved by the US Food and Drug Administration (FDA) for the risk reduction of invasive b...

    Brandy M. Heckman-Stoddard, Kathleen A. Foster in Current Breast Cancer Reports (2011)

  8. No Access

    Chapter

    Biomarkers for Early Detection and as Surrogate Endpoints in Cancer Prevention Trials: Issues and Opportunities

    In order to improve the early detection and diagnosis of cancer, give more accurate prognoses, stratify individuals by risk, predict response to treatment, and help the transition of basic research into clinic...

    Barbara K. Dunn, Karin Jegalian, Peter Greenwald in Clinical Cancer Prevention (2011)

  9. No Access

    Article

    Health disparities in breast cancer: biology meets socioeconomic status

    Breast cancer is the most common cancer in women worldwide, accounting for just over 1 million new cases annually. Population-based statistics show that globally, when compared to whites, women of African ance...

    Barbara K. Dunn, Tanya Agurs-Collins, Doris Browne in Breast Cancer Research and Treatment (2010)

  10. No Access

    Chapter and Conference Paper

    Seleneium and Vitamin E Cancer Prevention Trial: A Nutrient Approach to Prostate Cancer Prevention

    Prostate cancer continues to be both a major health threat, especially among African-American men, and a public health burden. However, growing evidence suggests that selenium and vitamin E may decrease the ri...

    Barbara K. Dunn, Anne Ryan, Leslie G. Ford in Cancer Prevention II (2009)

  11. No Access

    Chapter and Conference Paper

    Do We Make Optimal Use of the Potential of Cancer Prevention?

    Abstract Three decades of intensive experimental and clinical research on cancer prevention have yielded an impressive body of scientific knowledge about cancer epidemiology, causation, and preventative measur...

    Peter Greenwald, Barbara K. Dunn in Cancer Prevention II (2009)